跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,199 条关于
“MM120 ODT”
全部
3,199
临床试验
2,639
药物
342
机构
3
资讯
215
去年
MindMed's MM120 Advances in Phase III Trials for GAD and MDD, Stock Surges
去年
MindMed Appoints Matt Wiley as Chief Commercial Officer to Lead MM120 Launch Strategy
去年
MindMed Advances MM120 for GAD with Phase 3 Trials Underway
去年
MindMed Reports Strong Financial Position and Progress in Anxiety Treatment Development
去年
MindMed Reports Strong Financial Position with $273.7M Cash Reserve, Extending Operations Through 2027
去年
Altimmune and MindMed Join Nasdaq Biotechnology Index, Anticipate Key Clinical Data in 2025
前天
Definium Therapeutics to Report Phase 3 Panorama Topline Results for LSD-Based Anxiety Drug DT120
去年
Mind Medicine's MM120 Advances to Phase 3 Trials Following Strong Anxiety Treatment Results
11个月前
Single-Dose MM120 (LSD) Demonstrates Sustained Anxiety Relief in Phase 2b GAD Trial
去年
MindMed's MM120 Shows Promise in GAD Treatment, Prepares for Phase III Trials
第 1 页,共 22 页
上一页
下一页